(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 143.92% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.75%.
Uniqure Nv's revenue in 2026 is $18,093,000.On average, 16 Wall Street analysts forecast QURE's revenue for 2026 to be $1,533,864,303, with the lowest QURE revenue forecast at $648,964,421, and the highest QURE revenue forecast at $3,443,484,681. On average, 16 Wall Street analysts forecast QURE's revenue for 2027 to be $4,948,905,548, with the lowest QURE revenue forecast at $948,661,109, and the highest QURE revenue forecast at $11,721,092,087.
In 2028, QURE is forecast to generate $18,744,917,892 in revenue, with the lowest revenue forecast at $9,765,369,377 and the highest revenue forecast at $31,719,791,581.